Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct;28(5):481-486.
doi: 10.1177/1358863X231154756. Epub 2023 Jul 4.

Vascular Disease Patient Information Page: A guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism

Cassiopeia Frank  1 , Elizabeth V Ratchford  2 , Stephan Moll  1
Affiliations

Vascular Disease Patient Information Page: A guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism

Cassiopeia Frank et al. Vasc Med. 2023 Oct.
No abstract available

Keywords: anticoagulation; deep vein thrombosis (DVT); pulmonary embolism (PE); venous thromboembolism (VTE).

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interestsThe authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Cassiopeia Frank has served on an advisory board for Pfizer. Stephan Moll has been a consultant for Bristol Myers Squibb and Stago Diagnostica. Elizabeth Ratchford has no conflicts of interest to disclose.

Figures

Figure 1.
Figure 1.
Summary of risk factors for blood clots (deep vein thrombosis and pulmonary embolism).
Figure 2.
Figure 2.
Superficial and deep veins of the leg and arm. A health care provider can mark the location of the clot to help the patient understand which vein(s) are involved.
Figure 3.
Figure 3.
The similarities and differences between the two types of commonly prescribed blood thinners: warfarin and direct oral anticoagulants (DOACs).
Figure 4.
Figure 4.
Recurrence triangle. The recurrence triangle is a tool used to help determine how long to continue blood thinner. The triangle considers why the initial venous thromboembolism (VTE) occurred and the sex of the patient. The green top of the triangle indicates a low risk of another clot if blood thinner is stopped; for patients who are in this part of the triangle, short-term treatment (3–6 months) is recommended. If a patient is in the red zone of the triangle, risk for recurrence is high if blood thinner is stopped, and long-term treatment is recommended. Blood tests, including a ‘D-dimer’, or tests for a strong clotting disorder (thrombophilia), may also be used, particularly in patients with an intermediate risk of recurrence, to help determine whether to stop or continue blood thinners. On the right side, a patient’s preference for stopping or continuing the blood thinner is taken into consideration.
See this image and copyright information in PMC

References

    1. Vazquez SR. Vascular Disease Patient Information Page: Direct oral anticoagulants – 2020 update. Vasc Med 2020; 25: 196–199. - PubMed
    1. Lim MY, Moll S. Thrombophilia. Vasc Med 2015; 20: 193–196. - PubMed
    1. Moll S. Thrombophilia: Clinical–practical aspects. J Thromb Thrombolysis 2015; 39: 367–378. - PubMed
    1. Evans NS, Ratchford EV. Vascular Disease Patient Information Page: Compression therapy. Vasc Med 2021; 26: 352–355. - PubMed
    1. Barnett B, Frank C, Ratchford ER, Moll S. [Vascular Disease Patient Information Page: A guide for patients with newly diagnosed deep vein thrombosis or pulmonary embolism] [Article in Spanish]. Vasc Med 2023. DOI: 10.1177/1358863X231175929 - PMC - PubMed

Publication types